BRISTOL-MYERS SQUIBB COMPANY |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.91 USD | +1.71% |
|
+4.47% | -16.44% |
| 04:35pm | Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees | MT |
| 06-24 | Bristol Myers: accelerated approval in colorectal cancer | CF |
Presenter SpeechGregory Gilbert (Analysts)Okay. Good morning. We're going to go ahead and get ...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
Pharmaceuticals
Calendar
26/07/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.19
USD
Average target price
53.19
USD
Spread / Average Target
+26.08%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.44% | 85.52B | |
| +55.25% | 815B | |
| +45.34% | 654B | |
| -6.78% | 354B | |
| +21.61% | 337B | |
| +10.01% | 302B | |
| +17.81% | 247B | |
| +2.13% | 229B | |
| +12.96% | 219B | |
| +9.76% | 171B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Transcript : Bristol-Myers Squibb Company Presents at 40th Annual Deutsche Bank Health Care Conference, May-06-2015 10
